BioMarin Pharmaceutical Inc. (BMRN) and Other Top New Picks of Healthcare-Focused Visium Asset Management

Gottlieb purchased 1.66 million shares of Prosensa Holding NV (NASDAQ:RNA) valued at $31.06 million to initiate a position in the company engaged in the discovery and development of ribonucleic acid-modulating therapeutics for the treatment of genetic disorders. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) recently acquired Prosensa for about $680 million. D. E. Shaw also owns about 31,200 shares of Prosensa valued at $2.46 million. Prosensa Holding NV (NASDAQ:RNA) is up nearly 182% over the last 52 weeks.

Sientra Inc (NASDAQ:SIEN) is the last on this list of newly initiated positions. Visium revealed ownership of about 1.48 million shares of the producer of silicone gel breast implants valued at $24.77 million. The $273.86 million company had its IPO in late October. The stock is up about 10.7% since then. Samuel Islay of Orbimed Advisors is a prominent stakeholder of Sientra Inc (NASDAQ:SIEN). His fund had nearly 3.19 million shares valued at $53.48 million. Orbimed had also owned 33.8% of Sientra’s shares before the company went public.

Disclosure: None